Literature DB >> 21647567

Long-term therapeutic efficacy of the subthreshold micropulse diode laser photocoagulation for diabetic macular edema.

Yoko Takatsuna1,2, Shuichi Yamamoto3, Yosuke Nakamura3,4, Tomoaki Tatsumi3, Miyuki Arai3, Yoshinori Mitamura3,5.   

Abstract

PURPOSE: To investigate the long-term efficacy of subthreshold micropulse diode laser photocoagulation (SMDLP) on diabetic macular edema (DME).
METHODS: The effects of SMDLP (810 nm) were studied on 56 eyes of 44 patients with DME. Optical coherence tomography-determined foveal thickness and best-corrected visual acuity (BCVA) were evaluated at 1, 3, 6, and 12 months after the SMDLP.
RESULTS: The mean foveal thickness was 504 μm before the SMDLP, and it was significantly reduced to 439 μm at 1 month (P = 0.001), 409 μm at 3 months (P < 0.0001), 358 μm at 6 months (P < 0.0001), and 320 μm at 12 months (P < 0.0001). The mean BCVA at baseline was 0.47 logarithm of the minimal angle of resolution (logMAR) units, and it was not changed significantly at all of the postoperative examinations. Among the 56 eyes, 10 (17.8%) had an improvement of BCVA of >0.2 logMAR units, 36 (64.2%) remained the same, and 10 eyes (17.8%) had a reduction of >0.2 logMAR units at 12 months postoperatively.
CONCLUSION: Our results indicate that SMDLP has a beneficial effect on DME. However, prospective studies are needed to evaluate this technique in more detail.

Entities:  

Mesh:

Year:  2011        PMID: 21647567     DOI: 10.1007/s10384-011-0033-3

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  23 in total

1.  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

Authors:  S D Pendergast; T S Hassan; G A Williams; M S Cox; R R Margherio; P J Ferrone; B R Garretson; M T Trese
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

2.  A controlled study of vitrectomy for diabetic macular edema.

Authors:  Tomohiro Otani; Shoji Kishi
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

3.  Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy.

Authors:  Kyoko Maeshima; Noriko Utsugi-Sutoh; Tomohiro Otani; Shoji Kishi
Journal:  Retina       Date:  2004-08       Impact factor: 4.256

4.  A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.

Authors:  Ingrid U Scott; Allison R Edwards; Roy W Beck; Neil M Bressler; Clement K Chan; Michael J Elman; Scott M Friedman; Craig Michael Greven; Raj K Maturi; Dante J Pieramici; Michel Shami; Lawrence J Singerman; Cynthia R Stockdale
Journal:  Ophthalmology       Date:  2007-08-15       Impact factor: 12.079

5.  Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema.

Authors:  Jeffrey K Luttrull; Charles J Spink
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2006 Sep-Oct

6.  The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology.

Authors:  E Stefánsson
Journal:  Acta Ophthalmol Scand       Date:  2001-10

7.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

8.  Subthreshold micropulse diode laser photocoagulation for diabetic macular edema in Japanese patients.

Authors:  Kishiko Ohkoshi; Tatsuo Yamaguchi
Journal:  Am J Ophthalmol       Date:  2009-10-28       Impact factor: 5.258

9.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Ingrid Kreissig; Antje Söfker; Robert F Degenring
Journal:  Arch Ophthalmol       Date:  2003-01

10.  Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.

Authors:  Stela Vujosevic; Elisa Bottega; Margherita Casciano; Elisabetta Pilotto; Enrica Convento; Edoardo Midena
Journal:  Retina       Date:  2010-06       Impact factor: 4.256

View more
  11 in total

1.  Differential gene expression analysis using RNA sequencing: retinal pigment epithelial cells after exposure to continuous-wave and subthreshold micropulse laser.

Authors:  Tomoyasu Shiraya; Fumiyuki Araki; Suguru Nakagawa; Takashi Ueta; Kiyohito Totsuka; Hitoshi Abe; Yasuyuki Naito; Taku Toyama; Koichiro Sugimoto; Satoshi Kato
Journal:  Jpn J Ophthalmol       Date:  2022-05-31       Impact factor: 2.211

2.  Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema.

Authors:  Tomoaki Tatsumi; Yoko Takatsuna; Toshiyuki Oshitari; Tomomi Kaiho; Yohei Kawasaki; Yuki Shiko; Takeshi Sugawara; Takayuki Baba; Shuichi Yamamoto
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

3.  Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: A Meta-analysis of randomized controlled trials.

Authors:  Gang Qiao; Hai-Ke Guo; Yan Dai; Xiao-Li Wang; Qian-Li Meng; Hui Li; Xiang-Hui Chen; Zhong-Lun Chen
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

4.  The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema.

Authors:  Yoon Hyung Kwon; Dong Kyu Lee; Oh Woong Kwon
Journal:  Korean J Ophthalmol       Date:  2014-09-18

Review 5.  Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review.

Authors:  Jeffrey K Luttrull; Giorgio Dorin
Journal:  Curr Diabetes Rev       Date:  2012-07-01

6.  Central macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy.

Authors:  Mehmet Demir; Ersin Oba; Burcu Dirim; Erhan Ozdal; Efe Can
Journal:  BMC Ophthalmol       Date:  2013-04-09       Impact factor: 2.209

7.  Cental Macular Thickness in Patients with Type 2 Diabetes Mellitus without Clinical Retinopathy.

Authors:  Mehmet Demir; Burcu Dirim; Zeynep Acar; Murat Yılmaz; Yekta Sendul
Journal:  J Ophthalmol       Date:  2013-04-03       Impact factor: 1.909

8.  Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon's Capsule Triamcinolone Acetonide Injection.

Authors:  Toshiyuki Oshitari; Yuta Kitamura; Sakiko Nonomura; Miyuki Arai; Yoko Takatsuna; Eiju Sato; Takayuki Baba; Shuichi Yamamoto
Journal:  J Ophthalmol       Date:  2015-09-20       Impact factor: 1.909

9.  Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microaneurysm photocoagulation on diabetic macular edema.

Authors:  Toshiyuki Oshitari; Sakiko Nonomura; Miyuki Arai; Yoko Takatsuna; Eiju Sato; Takayuki Baba; Shuichi Yamamoto
Journal:  Int Med Case Rep J       Date:  2015-12-07

10.  The effect of posterior sub-Tenon's capsule triamcinolone acetonide injection to that of pars plana vitrectomy for diabetic macular edema.

Authors:  Sakiko Nonomura; Toshiyuki Oshitari; Miyuki Arai; Eiju Sato; Yoko Takatsuna; Takayuki Baba; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2014-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.